QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2029

Conditions
HER2-positive Metastatic Breast Cancer
Interventions
DIAGNOSTIC_TEST

CE-10-IVD

Leftover tumor tissue from a routine biopsy will be sent for analysis.

Trial Locations (36)

10467

RECRUITING

Montefiore Einstein Medical Center, The Bronx

15213

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

15232

RECRUITING

UPMC Hillman CC, Pittsburgh

19104

RECRUITING

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

20007

RECRUITING

Georgetown University - Lombardi CCC, Washington D.C.

20010

RECRUITING

MedStar Washington Hospital Center, Washington D.C.

20016

RECRUITING

Sibley Memorial Hospital, Washington D.C.

21287

RECRUITING

John's Hopkins Hospital, Baltimore

27599

RECRUITING

UNC Chapel Hill, Chapel Hill

46307

RECRUITING

University of Chicago Medicine Northwest Indiana, Crown Point

60451

RECRUITING

University of Chicago Comprehensive Cancer Center at Silver Cross, New Lenox

60462

RECRUITING

University of Chicago Medicine-Orland Park, Orland Park

60637

RECRUITING

University of Chicago Medical Center, Chicago

77030

RECRUITING

Ben Taub General Hospital, Houston

RECRUITING

MD Anderson Cancer center, Houston

77054

RECRUITING

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston

77079

RECRUITING

MD Anderson Cancer Center, Houston

77384

RECRUITING

MD Anderson Cancer center, Woodland

77478

RECRUITING

MD Anderson Cancer Center, Sugar Land

77573

RECRUITING

MD Anderson Cancer center, League City

94143

RECRUITING

University of California San Francisco Medical Center, San Francisco

98109

RECRUITING

University of Washington - Fred Hutchinson Cancer Center, Seattle

06418

RECRUITING

Smilow Cancer Hospital-Derby Care Center, Derby

06824

RECRUITING

Smilow Cancer Hospital Care Center, Fairfield

06033

RECRUITING

Smilow Cancer Hospital at Glastonbury, Glastonbury

06830

RECRUITING

Smilow Cancer Hospital Care Center at Greenwich, Greenwich

06437

RECRUITING

Smilow Cancer Hospital Care Center, Guilford

06105

RECRUITING

Smilow Cancer Hospital at Saint Francis, Hartford

06473

RECRUITING

Yale-New Haven Hospital North Haven Medical Center, New Haven

06511

RECRUITING

Yale Cancer Center, New Haven

06901

RECRUITING

Smilow Cancer Hospital Care Center at Long Ridge, Stamford

06790

RECRUITING

Smilow Cancer Hospital-Torrington Care Center, Torrington

06611

RECRUITING

Smilow Cancer Hospital Care Center, Trumbull

06708

RECRUITING

Smilow Cancer Hospital-Waterbury Care Center, Waterbury

06385

RECRUITING

Smilow Cancer Hospital Care Center - Waterford, Waterford

02891

RECRUITING

Smilow Cancer Hospital Care Center, Westerly

All Listed Sponsors
collaborator

Translational Breast Cancer Research Consortium

OTHER

collaborator

Danaher Inc.

UNKNOWN

lead

Abramson Cancer Center at Penn Medicine

OTHER